Need For Blinded Payment In Randomized Trials Is Recognized In Recent Bills
This article was originally published in The Gray Sheet
Executive Summary
Recent legislation is recognizing the need to blind patients and providers to sources of reimbursement in clinical trials to ensure scientifically valid results